These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 26142466)

  • 1. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome.
    Krasieva K; Gencer B; Locatelli I; Carballo D; Muller O; Fournier S; Matter CM; Räber L; Rodondi N; Mach F; Nanchen D
    Circ Cardiovasc Qual Outcomes; 2024 Aug; 17(8):e010790. PubMed ID: 38899458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Nanchen D; Gencer B; Muller O; Auer R; Aghlmandi S; Heg D; Klingenberg R; Räber L; Carballo D; Carballo S; Matter CM; Lüscher TF; Windecker S; Mach F; Rodondi N
    Circulation; 2016 Sep; 134(10):698-709. PubMed ID: 27462068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
    Nakamura M; Uno K; Hirayama A; Ako J; Nohara A; Arai H; Harada-Shiba M
    BMJ Open; 2017 Jul; 7(6):e014427. PubMed ID: 28674132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Hypercholesterolemia Among Young Adults With Acute Coronary Syndrome.
    Haskiah F; Erez D; Khaskia A
    Am J Cardiol; 2023 Jan; 186():189-195. PubMed ID: 36270825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.
    Al-Rasadi K; Al-Zakwani I; Alsheikh-Ali AA; Almahmeed W; Rashed W; Ridha M; Santos RD; Zubaid M
    J Clin Lipidol; 2018; 12(3):685-692.e2. PubMed ID: 29574074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome.
    Hauguel-Moreau M; Aïdan V; Hergault H; Beauchet A; Pépin M; Prati G; Pillière R; Ouadahi M; Josseran L; Rodon C; Rabès JP; Charron P; Dubourg O; Massy Z; Mansencal N
    Arch Cardiovasc Dis; 2022 Feb; 115(2):87-95. PubMed ID: 35123917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying familial hypercholesterolemia in acute coronary syndrome.
    Gencer B; Nanchen D
    Curr Opin Lipidol; 2016 Aug; 27(4):375-81. PubMed ID: 27092769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.
    Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB
    Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
    Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
    Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.